1600P The role of C-reactive protein/albumin ratio in predicting 90-day mortality in patients with febrile neutropenia

The MASCC score is widely used to predict the prognosis of febrile neutropenia after chemotherapy in cancer patients. does not use any laboratory data and has low sensitivity. Therefore, search for markers continues. Albumin(alb) C-Reactive Protein(CRP) are acute phase reactants, besides albumin reflects nutritional status. In this study, we aimed evaluate effect CRP/alb ratio on neutropenia. files patients admitted with diagnosis between January 2018 2022 were reviewed retrospectively, risk score, CRP levels at admission collected. All who followed up by medical oncology department, received least 1 course presented included study. A total one hundred fifty-six (n=156) episodes 55 (35%) these died within ninety days. While 90-day mortality rate was 45% group <21, 26% >21 (p = 0.007). median determined as 58 divided into two groups according value. 24% a ratio, high CRP/Alb 0.004). <58 (n=47), 21%, compared 55% <21 >58 (p= 0.001). conclusion, worsens independently other factors. combined evaluation beneficial predicting increases prognostic power score.